DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-95,242

TEVA PHARMACEUTICALS USA, INC.
US TAPI MISSOURI DIVISION
A WHOLLY OWNED SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES
LTD.
MEXICO, MISSOURI

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended ("Act"), 19 U.S.C. § 2273, the Department of Labor
herein presents the results of an investigation regarding
certification of eligibility to apply for worker adjustment
assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the
workers in such workers' firm have become totally or
partially separated, or are threatened to become
totally or partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of
articles or supply of services like or directly
competitive with those produced/supplied by the
workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have contributed
importantly to the workers' separation or
threat of separation.

The investigation was initiated in response to a petition
filed on October 2, 2019 by a company official on behalf of
workers of Teva Pharmaceuticals USA, Inc., US TAPI Missouri
Division, a wholly owned subsidiary of Teva Pharmaceutical
Industries Ltd., Mexico, Missouri (Teva Pharmaceuticals-
Missouri). The workers' firm is engaged in activities related
to the production of Amoxicillin, Dicloxacillin, Cefprozil,
Cefdinir, Cephalexin, and Cefadroxil. There are no on-site
leased workers. Workers are not separately identifiable by
article.
During the course of the investigation, information was
collected from the workers' firm.
Section 222(a)(1) has been met because a significant
number or proportion of the workers in such workers' firm have
become totally or partially separated, or are threatened to
become totally or partially separated.
Section 222(a)(2)(B) has been met because the workers'
firm has acquired from a foreign country articles like or
directly competitive with articles produced by the workers which
contributed importantly to worker group separations at Teva
Pharmaceuticals-Missouri.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Teva Pharmaceuticals-
Missouri, who are engaged in activities related to the
production of Amoxicillin, Dicloxacillin, Cefprozil, Cefdinir,
Cephalexin, and Cefadroxil, meet the worker group certification
criteria under Section 222(a) of the Act, 19 U.S.C. § 2272(a).
In accordance with Section 223 of the Act, 19 U.S.C. § 2273, I
make the following certification:
"All workers of Teva Pharmaceuticals USA, Inc., US TAPI
Missouri Division, a wholly owned subsidiary of Teva
Pharmaceutical Industries Ltd., Mexico, Missouri, who
became totally or partially separated from employment on or
after October 1, 2018 through two years from the date of
certification, and all workers in the group threatened with
total or partial separation from employment on the date of
certification through two years from the date of
certification, are eligible to apply for adjustment
assistance under Chapter 2 of Title II of the Trade Act of
1974, as amended."
Signed in Washington, D.C. this 10th day of October 2019.

/s/Jessica R. Webster
______________________________
JESSICA R. WEBSTER
Certifying Officer, Office of
Trade Adjustment Assistance